0 Comments
Zika Virus Testing Market is anticipated to be driven by increasing Zika incidences around the globe. This virus was first detected in Rhesus monkeys in Uganda in 1947. Then, in 1952, humans were detected with the virus.
The “Zika Virus Testing Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. The Zika Virus Testing Market Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the major players such As, ARUP Laboratories, Hologic, Luminex Corporation, Roche Molecular Systems, etc. Various application sub-segments of the industry comprise hospitals, ambulatory centers, pathology laboratories, diagnostic centers, etc. The different screening tests include nucleic acid amplification and Zika virus antibody. Based on geographies, the market is classified on the basis of Europe, Asia Pacific, Americas, and the Middle East and Africa. The steady transfer of Zika in Americas has led to the demand for effective screening services till the end of the forecast period. The continuous demand for the better identification & management of this illness should propel industry sales. Zika Virus Testing Market Segment by Regions, regional analysis covers:
For Market Zika Virus Testing Market analysis, the report covers upstream raw materials, equipment, downstream client survey, Marketing channels, Market development trend and proposals, which more specifically include valuable information By key applications and consumption, key regions and consumption, key Global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply. About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.
The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023. Market Dynamics: Oncology Segment Is Expected To Be The Largest Driver Of Market Growth The growing incidence of cancer is the prime drivers of the market. According to W.H.O. cancer was responsible for 8.8 million deaths in 2015, indenting nearly 1 in 6 patient’s deaths. Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015. According to the estimates of the Centers for Disease Control and Prevention, almost 1.5 million people are diagnosed with cancer per year in the U.S. alone, resulting in more than five lakh deaths. Technology Development Is Expected To Drive A Faster Market Adoption The development of highly sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a broad adoption. The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption. The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth. Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market. Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others. High Cost Of Installation And Maintenance And Nascent Stage Of Technology May Hamper The Market Growth The prime market constraints include prohibitive costs of molecular diagnostics, the high cost of manufacturing, consolidated nature of the market has put a premium on the price of the epigenetics products, nascent stage of technology and high power of firms relative to buyers. Segments: To generate a bird’s view of the global epigenetics market, the report is segmented based on instruments, consumables, applications, technology, end users, and regions. Based on instruments, the market comprises of NGS, spectrometer, PCR, software solutions and others. Based on consumables, the market comprises of kit, enzymes, reagent, and others. Based on application, the market comprises of oncology, developmental biology, drug discovery, cardiology, immunology, and others . Based on technology, the market comprises of methylation, histone modification, and others. Based on end users the market is segmented into academia and research, pharmaceutical and biotechnology industry and others. Based on the regions, the market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world. Regional analysis: North America led by the U.S. accounts for the most significant market share of the market, owing to faster technology uptake, the large biotech sector of the U.S., the presence of large advanced players, growing prevalence of cancer. Europe led by Germany, U.K., and France accounts for the second-largest and second fastest market during the forecasted period. Asia led by Japan and supported by China, South Korea, and India is anticipated to be the fastest growing market. The Middle East and Africa market will expand at a slower rate on account of the weak industry landscape and low demand due to weak economic conditions. Key Vendors: Some of the dominant vendors operating in the report are Bio-Rad (US), Illumina (US), QIAGEN (Netherlands), Thermo Fisher (US), Active Motif (US), Diagenode (Belgium), Agilent (US), Merck Millipore (US), Abcam (UK), New England Biolabs (US), PerkinElmer (US), Zymo Research (US), and others. Access Report @ https://www.marketresearchfuture.com/upcoming-reports/epigenetics-market-6161 Intended Audience
Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR’s Outlook towards the Worldwide Ophthalmic Equipment Market Remains Positive with a 5.4 % CAGR forecast for the Next Five Years. And Provide Overview of Key Players and their Strategic Profiling in the Market, Comprehensively Analyzing their Core Competencies, and Drawing a Competitive Landscape for the Market.
Ophthalmic Equipment Market – Key Players Some of the key players in this market are Alcon (U.S.), Bausch & Lomb (U.S.), Carl Zeiss Meditec (Germany), Johnson & Johnson (U.S.), Essilor International S.A. (France), Haag-Streit (Switzerland), Nidek (Korea), Staar Surgical (U.S.), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Hoya Corporation (Japan), Ridex Corporation (U.S.), and others. Ophthalmic Equipment Market – Highlights The market in Asia Pacific is expected to grow rapidly in the coming years. Based on a detailed study and analysis, it is found that this region has a good growth potential due to the increasing unhealthy eating habits and unhygienic conditions. Major factors driving the market are increasing geriatric population and increasing healthcare expenditure. On the other hand, low awareness in developing and underdeveloped regions regarding ophthalmic diseases may hamper the market growth during the forecast period. Ophthalmic Equipment Market – Segmentation The global ophthalmic equipment market is segmented on the basis of product, application, and end-user. On the basis of product, the market is segmented into vision care devices, ophthalmology surgical devices, diagnostic and monitoring devices, and others. Vision care devices a segmented into spectacles and contact lens. Contact lenses are further segmented into soft contact lenses, Rigid Gas Permeable lenses (RGP), and hybrid contact lenses. Ophthalmology surgical devices are segmented into cataract surgical devices, vitreoretinal surgical devices, refractive surgical devices, glaucoma surgical devices, ophthalmic microscopes, ophthalmic accessories, and others. Cataract surgical devices are further segmented into Intraocular Lenses (IOLS), Ophthalmic Viscoelastic Devices (OVDS), phacoemulsification devices, cataract surgical lasers, and others. The vitreoretinal surgical devices segment is further segmented into vitreoretinal packs, vitrectomy machines, photocoagulation lasers, illumination devices, vitrectomy probes, and others. The refractive surgical devices segment is further segmented into femtosecond lasers, excimer lasers, and others. Glaucoma surgical devices are further segmented into Glaucoma Drainage Devices (GDDS), and micro-invasive glaucoma surgical devices. Ophthalmic accessories are further segmented into surgical instruments and kits, ophthalmic forceps, ophthalmic spatulas, ophthalmic tips and handles, ophthalmic scissors, macular lenses, ophthalmic cannulas, and others. Diagnostic and monitoring devices are segmented into optical coherence tomography scanners, fundus cameras, perimeters/visual field analyzers, autorefractors and keratometers, ophthalmic ultrasound imaging systems, tonometers, slit lamps, phoropters, wavefront aberrometers, optical biometry systems, ophthalmoscopes, lensmeters, corneal topography systems, chart projectors, specular microscopes, retinoscopes, and others. Ophthalmic ultrasound imaging systems are further segmented into ophthalmic A-scan ultrasound, ophthalmic b-scan ultrasound, ophthalmic ultrasound biomicroscopes, and ophthalmic pachymeters. On the basis of application, the market is segmented into glaucoma, amblyopia, cataract, retinal detachment, and others. On the basis of end-user, the market is segmented into hospitals, ophthalmology clinics, diagnostic centers, research centers, and others. Ophthalmic Equipment Market – Regional Analysis The Americas dominates the global ophthalmic equipment market owing to the increasing prevalence of ophthalmic diseases and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for the market growth. Europe is the second largest in the global ophthalmic equipment market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region. Asia Pacific is estimated to be the fastest growing market for ophthalmic equipment. This can be attributed to the presence of developing economies such as India and China and a huge patient population suffering from ophthalmic diseases. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region. On the other hand, the Middle East and Africa has the least share in the global ophthalmic equipment market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region. Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/ophthalmic-equipment-market-5973 Related Healthcare News Telemedicine Market Infection Control Market About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions Contact: www.marketresearchfuture.com Market Highlights
The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, gynandroblastoma, Sex Cord Tumor with Annular Tubules (SCTAT), and Sertoli Leydig cell tumor. In humans, this type of tumor accounts for 8% of the ovarian cancers and around 5% of testicular cancers. It is noted that the increasing cases of ovarian and testicular cancer, technological advancements, and increasing healthcare expenditure are the key factors driving the sex cord gonadal stromal tumor market. Various other factors such as the growing awareness about the cord-gonadal stromal tumor, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement are continuously contributing to the growth of the global sex cord-gonadal stromal tumor market. Owing to the increasing cases of ovarian and testicular cancer, technological advancements, increasing healthcare expenditure, growing awareness about sex cord-gonadal stromal tumor, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the sex cord-gonadal stromal tumor market has evolved significantly. However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in low and middle-income countries are likely to hamper the growth of the sex cord-gonadal stromal tumor market over the forecast period. It is estimated that the sex cord-gonadal stromal tumor market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023. Key Players Some of the key players in the global sex cord-gonadal stromal tumor market are Abbott, Abcam plc, Affymetrix, Inc., Agilent Technologies, Inc., Beckman, Dickinson and Company (BD), Bio SB Inc., BioCurex, BioModa, Inc., Bio-Rad Laboratories, Inc., Boston Scientific Corporation, Cell Signaling Technology, Inc., Clarient, Inc., CooperSurgical Inc., Correlogic Systems, Inc., Danaher Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Gen-Probe, Inc., Hologic, Inc., Johnson & Johnson Services, Inc., Karl Storz GmbH & Co. Kg, LiNA Medical USA, Merck Millipore, PerkinElmer, Inc., Qiagen, Radient Pharmaceuticals, Thermo Fisher Scientific Inc., Veridex LLC, and others. Regional Analysis The Americas dominates the sex cord-gonadal stromal tumor market owing to the increasing prevalence of ovarian cancer in this region and high healthcare expenditure. According to the American Cancer Society, around 22,240 women are likely to be diagnosed with ovarian cancer, and 14,070 women are likely to die from ovarian cancer, in 2018. Europe holds the second position in the sex cord-gonadal stromal tumor market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European sex cord-gonadal stromal tumor market. The increasing healthcare expenditure is also boosting the European sex cord-gonadal stromal tumor market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association. Asia Pacific is the fastest growing sex cord-gonadal stromal tumor market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015-2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014-2015. The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities. Segmentation The global sex cord-gonadal stromal tumor market is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of tumor type, the sex cord-gonadal stromal tumor market is classified as granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, Sertoli Leydig cell tumor, gynandroblastoma, and Sex Cord Tumor with Annular Tubules (SCTAT). The granulosa cell tumor is further classified as functioning tumors and non-functioning tumors. On the basis of diagnosis, the sex cord-gonadal stromal tumor market is classified as microscopy immunohistochemistry, tumor marker, ultrasound, Magnetic Resonance Imaging (MRI), and others. The tumor marker segment is further classified as inhibin-alpha, calretinin, Melan-A, and others. On the basis of treatment, the sex cord-gonadal stromal tumor market is classified as chemotherapy, radiotherapy, surgery, and others. The surgery segment is further classified as salpingo-oophorectomy, abdominal hysterectomy, Retroperitoneal Lymph Node Dissection (RPLND), and radical inguinal orchiectomy. The sub-segment of salpingo-oophorectomy includes unilateral salpingo-oophorectomy and bilateral salpingo-oophorectomy. On the basis of end-user, the sex cord-gonadal stromal tumor market is segmented into hospitals and clinics, cancer research centers, research and academic institutes, and others. Get full report @https://www.marketresearchfuture.com/reports/sex-cord-gonadal-stromal-tumor-market-5912 Intended Audience Medical Device Companies Research and Development (R&D) Companies Diagnostic Laboratories Government Research Institutes Academic Institutes and Universities Browse other healthcare related report Sex Cord Gonadal Stromal Tumor Market Endometrial Cancer Market About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: https://www.marketresearchfuture.com Home Healthcare Market Size Research Report — Forecast to 2023 includes a vast number of healthcare services that are provided to the patient in their home in case of illness or injuries. Home healthcare is typically less expensive, convenient, and just as effective as a hospital or a nursing facility.
Technological advancements in healthcare and diagnosis equipment and changing government initiatives encouraging the adoption of home healthcare are most likely to boost the market demand. The patient demand has prompted prominent market players to take notice. However, concerns related to patient safety can impede the growth of the market. Home Healthcare Market Segmentation By product, the Home Healthcare Market is segmented into testing, screening and monitoring products and therapeutic products. The testing, screening, and monitoring segment is expected to continue to lead the global market owing to the increasing demand for home healthcare solutions. This segment is anticipated to register a CAGR of 8.5% during the forecast period. The testing, screening, and monitoring products are further segmented into blood glucose monitors, blood pressure monitors, sleep apnea monitors, pulse oximeters and heart rate monitors, cholesterol monitoring devices, Holter and event monitors, and others. Therapeutic products are segmented into respiratory therapy equipment, insulin delivery devices, IV equipment, wound care products, dialysis equipment, and others. Service-wise, the market is segmented into skilled nursing services, rehabilitation therapy services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. Among these, the skilled nursing segment is touted to be a major services segment, projected to reach the value of USD 134166.3 million by the end of 2023. On the other hand, the segment of infusion therapy services is predicted to surge at a CAGR of 8.50% during the assessment period. By software, the market is segmented into clinical management systems, agency software, telehealth solutions, and hospice solutions. Among these segments, the clinical management systems market is projected to lead the global market and is estimated to register a CAGR of 8.3% Competitive Analysis The report identifies various key market players including Fresenius SE & Co KGaA (Germany), GE Healthcare (U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott (U.S.), B. Braun Melsungen AG (Germany), Koninklijke Philips N.V. (The Netherlands), 3M (U.S.), Medtronic PLC (U.S.), A&D Company (Japan), McKesson Corporation (U.S.), Kinnser Software (U.S.), Becton Dickinson Company (U.S.), Apple (U.S.), Omron Corporation (Japan), LG Electronics (South Korea), and others. Get Home Healthcare Market Research Report, by Product (Therapeutic products, Other), Service (Skilled Nursing Services, Respiratory Therapy Service, Other), Software (Clinical Management System, Telehealth Solution, Other) — Global Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/home-healthcare-market-2030 On Feb 2019, Air Liquide continued on its pursuit of developing its home healthcare activity in Europe with a big acquisition of Megamed AG and Sleep & Health SA, two historic market players who are based in Switzerland. This will help patients and healthcare professional’s needs to be addressed in a better manner. Regional Analysis The home healthcare market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas holds the major share of the global market and is poised to retain its pole position towards the end of the assessment period. The factors that are favoring the proliferation of the home healthcare market in the region include the consolidation of key players, increasing healthcare expenditure, the large-scale prevalence of chronic diseases, growing government initiatives, etc. The regional market encompasses North America and South America, out of which, North America’s home healthcare market is likely to exhibit a relatively higher growth rate over the next couple of years. Europe has secured the second spot in the global home healthcare market. It is expected to grow substantially in the forthcoming years due to the presence of well-developed technologies and increasing support from government and private organizations for research & development. Asia Pacific is projected to strike the highest CAGR over the assessment period. The growth-inducing factors supporting the regional home healthcare market include growing geriatric population, huge patient pool, and availability of skilled labor force. Meanwhile, the Middle East & Africa is prognosticated to account for the least share of the home healthcare market owing to the prevailing poor economic conditions, especially in the African region. Related Report Medical Tourism Market Laser Therapy Market About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: https://www.marketresearchfuture.com |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |